CardioBeat provides innovative solutions to various key biomedical research and development challenges, especially in the field of cardiovascular diseases.
In particular, the company and its team hold specific know-how related to cardiac and vascular surgery, bio-artificial organs and tissue engineering for vascular grafts.
The company is based in Geneva, Switzerland, and was founded in 2013 by Beat H. Walpoth, MD, a Swiss cardiovascular surgeon with more than 40 years practice and expertise in biomedical research, development and teaching.